Aurora Cannabis Stock Filter Stocks by Fundamentals
ACB Stock | USD 6.54 0.75 12.95% |
Aurora Cannabis fundamentals help investors to digest information that contributes to Aurora Cannabis' financial success or failures. It also enables traders to predict the movement of Aurora Stock. The fundamental analysis module provides a way to measure Aurora Cannabis' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aurora Cannabis stock.
Aurora | Price to Earnings To Growth |
Aurora Cannabis Current Valuation Drivers
We derive many important indicators used in calculating different scores of Aurora Cannabis from analyzing Aurora Cannabis' financial statements. These drivers represent accounts that assess Aurora Cannabis' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Aurora Cannabis' important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 1.6B | 1.9B | 3.7B | 304.2M | 273.8M | 260.1M | |
Enterprise Value | 2.0B | 1.9B | 3.5B | 230.9M | 207.8M | 197.4M |
Aurora Fundamentals
Return On Equity | -1.37 | ||||
Return On Asset | -0.0826 | ||||
Profit Margin | 1.52 % | ||||
Operating Margin | (0.24) % | ||||
Current Valuation | 318.31 M | ||||
Shares Outstanding | 54.54 M | ||||
Shares Owned By Institutions | 6.96 % | ||||
Number Of Shares Shorted | 5.08 M | ||||
Price To Earning | 46.94 X | ||||
Price To Book | 0.95 X | ||||
Price To Sales | 1.31 X | ||||
Revenue | 233.29 M | ||||
Gross Profit | 21.23 M | ||||
EBITDA | (210.74 M) | ||||
Net Income | (265.33 M) | ||||
Cash And Equivalents | 439.14 M | ||||
Cash Per Share | 1.46 X | ||||
Total Debt | 227.52 M | ||||
Debt To Equity | 0.41 % | ||||
Current Ratio | 5.13 X | ||||
Book Value Per Share | 10.85 X | ||||
Cash Flow From Operations | (115.82 M) | ||||
Short Ratio | 1.36 X | ||||
Earnings Per Share | (57.56) X | ||||
Target Price | 31.8 | ||||
Number Of Employees | 1.13 K | ||||
Beta | 2.93 | ||||
Market Capitalization | 323.18 M | ||||
Total Asset | 926.32 M | ||||
Retained Earnings | (6.3 B) | ||||
Working Capital | 599.89 M | ||||
Current Asset | 174.76 M | ||||
Current Liabilities | 105.1 M | ||||
Net Asset | 926.32 M |
About Aurora Cannabis Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aurora Cannabis's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aurora Cannabis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aurora Cannabis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aurora Cannabis
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aurora Cannabis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aurora Cannabis will appreciate offsetting losses from the drop in the long position's value.Moving together with Aurora Stock
0.68 | YS | YS Biopharma Report 22nd of April 2024 | PairCorr |
Moving against Aurora Stock
0.85 | VERV | Verve Therapeutics Financial Report 20th of May 2024 | PairCorr |
0.64 | VAXX | Vaxxinity Financial Report 14th of May 2024 | PairCorr |
0.56 | VCNX | Vaccinex | PairCorr |
0.51 | DMAC | DiaMedica Therapeutics Financial Report 20th of May 2024 | PairCorr |
0.5 | DRUG | Bright Minds Biosciences | PairCorr |
The ability to find closely correlated positions to Aurora Cannabis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aurora Cannabis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aurora Cannabis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aurora Cannabis to buy it.
The correlation of Aurora Cannabis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aurora Cannabis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aurora Cannabis moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aurora Cannabis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Aurora Cannabis Piotroski F Score and Aurora Cannabis Altman Z Score analysis. For information on how to trade Aurora Stock refer to our How to Trade Aurora Stock guide.Note that the Aurora Cannabis information on this page should be used as a complementary analysis to other Aurora Cannabis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Aurora Stock analysis
When running Aurora Cannabis' price analysis, check to measure Aurora Cannabis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aurora Cannabis is operating at the current time. Most of Aurora Cannabis' value examination focuses on studying past and present price action to predict the probability of Aurora Cannabis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aurora Cannabis' price. Additionally, you may evaluate how the addition of Aurora Cannabis to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Transaction History View history of all your transactions and understand their impact on performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is Aurora Cannabis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aurora Cannabis. If investors know Aurora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aurora Cannabis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.92) | Earnings Share (57.56) | Revenue Per Share 6.784 | Quarterly Revenue Growth 0.055 | Return On Assets (0.08) |
The market value of Aurora Cannabis is measured differently than its book value, which is the value of Aurora that is recorded on the company's balance sheet. Investors also form their own opinion of Aurora Cannabis' value that differs from its market value or its book value, called intrinsic value, which is Aurora Cannabis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aurora Cannabis' market value can be influenced by many factors that don't directly affect Aurora Cannabis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aurora Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aurora Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aurora Cannabis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.